Immunoglobulin heavy constant delta (IGHD) was down‐regulated in NAFLD patients by 67%; however, it was not significant in an up‐front one‐way ANOVA across all five experimental groups and was therefore excluded from this panel (Table EV1). The gene discussed is IGHD; the disease is metabolic dysfunction-associated steatotic liver disease.